Cellect(QNRX) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results Quoin Initiates Peeling Skin Syndrome Clinical Program Further Expansion of International Reach for Netherton Syndrome Clinical Trials Significant Insider Share Purchases by the Entire Management Team ASHBURN, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a clinical-stage, specialty pharmaceutical company focused on developing and comm ...